Advisor Group Holdings, Inc. Vyne Therapeutics Inc. Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$0.5 - $1.15 $250 - $575	-500 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$1.39 - $3.47 $625 - $1,561	-450 Reduced 47.37%	500 $1,000
Q2 2021 Aug 02, 2021	BUY	$3.24 - $6.92 $1,620 - $3,460	500 Added 111.11%	950 $3,000
Q1 2021 May 13, 2021	BUY	$6.34 - $12.68 $2,853 - $5,706	450 New	450 $3,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $170M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.